Customers will be able to access Teladoc on Alexa for 24/7 non-emergency general medical care through certain smart speakers, including Echo, Echo Dot and Echo Show. The partnership is evidence of a broader shift in healthcare where companies that otherwise compete are finding opportunities to collaborate.
By Frank Vinluan Monday, February 28, 2022 6:31 PM
Biocon Biologics is acquiring the biosimilars business of its longtime partner, Viatris. The deal gives Biocon a biosimilars presence in both emerging and developed markets, while Viatris sheds non-core assets as part of a broader strategic review.
By Scott Andrews Monday, February 28, 2022 6:19 PM
At a time of dramatically increasing consumer demand for convenience and digital self-service, hospitals and health systems have a significant opportunity to close the gap between expectations and reality for people trying to find care.
The 2021 HIMSS Healthcare Cybersecurity Survey found heathcare cyber attacks most frequently targeted financial information; aging infrastructures and tight budgets contributed to security challenges.
By Manisha Shetty Gulati Monday, February 28, 2022 2:00 PM
To avoid the "trends trap" of heightening the health tech disconnect in the wake of innovation, we must consider how best to proceed in investing and building new technologies that enable long-term transformation of care delivery, not just this year's trends.
By Michael Schroeder Monday, February 28, 2022 1:42 PM
Customers will be able to access Teladoc on Alexa for 24/7 non-emergency general medical care through certain smart speakers, including Echo, Echo Dot and Echo Show. The partnership is evidence of a broader shift in healthcare where companies that otherwise compete are finding opportunities to collaborate.
By Angela Hart, Kaiser Health News Monday, February 28, 2022 12:58 PM
The death of single-payer in the nation's most populous state deals a major blow to similar campaigns elsewhere in the nation — which had looked to California for inspiration and leadership — casting doubt on their ability to succeed.
By Frank Vinluan Monday, February 28, 2022 12:04 PM
Celyad Ocology has voluntarily paused a clinical study evaluating its off-the-shelf CAR T-cell therapy in colorectal cancer following the report of two patient deaths. The investigation is ongoing, but the company said that both patients exhibited "similar pulmonary findings."
By Arundhati Parmar Monday, February 28, 2022 11:53 AM
In this episode, I speak with John Martin, chief medical officer of Butterfly Network about how it is trying to transform the practice of medicine through a handheld ultrasound probe and data platform.
MedCity INVEST 2022 at The Ritz Carlton Chicago is a 3 day gathering with numerous opportunities for in-person networking and learning around the latest technologies and investment trends from VCs and successful entrepreneurs.
.png?width=200&height=166&upscale=true&name=MedCity_News%20(1).png)
No comments